Jun 26, 2025 05:06AM

Feb 27, 2023 04:05PM

Nov 4, 2022 06:10AM

Nov 3, 2022 11:19AM

Nov 2, 2022 04:05PM

Sep 12, 2022 07:30AM

Sep 12, 2022 07:30AM Acadia Pharmaceuticals Announces Trofinetide New Drug Application for the Treatment of Rett Syndrome has been Accepted for Filing and Review by U.S. FDA

Jun 21, 2022 10:18AM

Jun 21, 2022 08:42AM

Jun 21, 2022 08:08AM

Apr 27, 2022 09:21AM

Mar 1, 2022 06:19AM

Mar 9, 2021 08:50AM

Mar 9, 2021 06:47AM Acadia Pharmaceuticals (ACAD) PT Lowered to $36 as RBC Capital Sees a CRL Likely

Mar 9, 2021 06:19AM

Mar 9, 2021 05:10AM

Mar 8, 2021 04:09PM

Mar 8, 2021 04:05PM

Feb 25, 2021 07:27AM

Feb 24, 2021 04:05PM

Nov 16, 2020 05:41AM UPDATE: Raymond James Upgrades Acadia Pharmaceuticals (ACAD) to Strong Buy

Nov 4, 2020 04:05PM

Aug 25, 2020 09:02AM

Aug 25, 2020 09:00AM

Aug 5, 2020 04:05PM

Jul 20, 2020 04:03PM

Jul 20, 2020 04:03PM

Jul 20, 2020 04:02PM ACADIA Pharmaceuticals Announces Top-line Results from the Phase 3 CLARITY Study Evaluating Pimavanserin for the Adjunctive Treatment of Major Depressive Disorder

Sep 18, 2019 09:26AM

Jun 24, 2016 11:13AM

Mar 30, 2016 10:44AM

Mar 30, 2016 06:49AM

Mar 29, 2016 05:14PM

Mar 29, 2016 05:13PM

Mar 2, 2016 07:17AM Deep Dive into Pimavanserin in PDP Suggests Positive AdCom for Acadia Pharma (ACAD) - Leerink

Feb 29, 2016 07:00AM

Jan 29, 2016 04:06PM

Jan 29, 2016 04:05PM

Jan 22, 2016 06:31AM

Nov 6, 2015 12:16PM

Nov 6, 2015 12:00PM

Nov 6, 2015 09:43AM Piper Jaffray Downgrades Acadia Pharmaceuticals (ACAD) to Neutral

Nov 5, 2015 04:01PM

Nov 2, 2015 09:28AM

Nov 2, 2015 08:12AM

Nov 2, 2015 08:00AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All